[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Nervgen Pharma Corp (NGEN)

Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nervgen Pharma Corp 112-970 BURRARD STREET UNIT 1290 VANCOUVER A1 V6Z 2R4 CAN

https://nervgen.com Employees: 9 P: 778-731-1711

Sector:

Medical

Description:

NervGen Pharma Corp. is a clinical-stage biopharmaceutical company developing neuroreparative therapeutics for spinal cord injury and other neurotraumatic and neurologic conditions. NervGen Pharma Corp. is based in VANCOUVER, British Columbia.

Key Statistics

Overview:

Market Capitalization, $K 183,839
Enterprise Value, $K 168,039
Shares Outstanding, K 80,631
Float, K 75,954
% Float 94.20%
Short Interest, K 5,336
Short Float 6.62%
Days to Cover 13.83
Short Volume Ratio 0.68
% of Insider Shareholders 5.80%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -31,570 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -21,100 K
EBIT, $ -23,370 K
EBITDA, $ -23,330 K

Growth:

1-Year Return -16.27%
3-Year Return 50.99%
5-Year Return 39.93%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 08/13/26
Next Earnings Date 11/12/26
Earnings Per Share ttm -0.46
EPS Growth vs. Prev Qtr -311.11%
EPS Growth vs. Prev Year 115.38%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NGEN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,259.82%
Return-on-Assets % -199.79%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 15.09
Book Value/Share 0.15
Interest Coverage -2.95
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.